Let's spread the word about Immunotherapy! Click to share this page with your community.

Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting

CRI's Vanessa M. Lucey, Ph.D., MBA, director of the CRI Venture Fund and Clinical Accelerator, is presenting poster #P387 for "Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations" (PORTER) in conjunction with our clinical study partners. 

Learn more about the PORTER poster

View Clinical Accelerator Portfolio

The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting provides a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.

The Annual Meeting consists of cutting-edge research presentations by experts in the field, both oral and poster abstract presentations, and ample opportunity for structured and informal discussions, including important networking opportunities. In addition, the meeting includes updates on major national and international initiatives coming from academia, government and industry, as well as important society projects.

Photo by Sharosh Rajasekher on Unsplash

*Immunotherapy results may vary from patient to patient.

Top